Responses will be analyzed by Karmanos Cancer Institute’s Office of Cancer Health Equity and Community Engagement’s (OCHECE) research study team who will create reports, presentations and publications based on the data. Specific reports will be provided to community partner organizations and other social service agencies so they may develop and implement strategies to increase access to appropriate cancer resources based on survey results, in collaboration with partner organizations. Results will inform practical policies and systems change to support vulnerable populations that disproportionately carry the COVID-19 burden.
“We’re pleased to offer our community the opportunity to participate in this survey, which will directly impact health care now and in the future. Our valuable tax dollars are being put to work through this survey and we encourage the public to share their experiences,” said Hayley Thompson, Ph.D., Associate Center Director, Community Outreach & Engagement, Karmanos Cancer Institute and Principal Investigator for this study.
The survey will cover a variety of topics including demographics, mood and well-being, dietary habits, financial hardship, health care needs and cancer control. It will also examine differences in the habits of individuals living in rural and urban areas throughout the state. Furthermore, the survey will address perceived stigma related to COVID-19 and its variability across racial/ethnic groups as well as perceptions of the racism and inequality that inform COVID-19 disparities.
The survey will take 30-40 minutes to complete and can be accessed online beginning on June 25 at www.karmanos.org/covid19survey. Participants may also take the survey via phone beginning on June 29 by calling 313-576-8869. The survey will be available in Spanish and Arabic starting in early July. It will remain open until September 1 or until 2,000 responses are collected. Participants who complete the survey will receive a $10 electronic gift card to Meijer or Target. Individual responses will be kept confidential. Data will be reported for the entire group or subgroups; the information of any individual will never be reported.
Cancer is the second leading cause of death in the state of Michigan. However, expected cancer mortality in 2020 may be underestimated due to the COVID-19 pandemic. At the height of infections in the state, Michigan, ranked fifth in COVID-19 incidence and mortality. This is largely driven by the predominantly African American city of Detroit, which accounts for one-third of Michigan’s COVID-19 cases and more than 40% of related deaths. COVID-19-related disruptions in daily life and routines may have a broad range of adverse consequences including limited access to care, resources and information, as well as psychological distress, which undermines prevention and control efforts at the population and individual level and across the cancer care continuum. This may also exacerbate persistent racial disparities in cancer care and outcomes.
This survey is offered in partnership with a variety of community organizations including St. Patrick’s Senior Center, Detroit Parent Network, LGBT Detroit, Faith-Based Genetic Research Institute (Detroit), Western Wayne Family Health Centers (Inkster), Area Agency on Aging of Northwest Michigan (Traverse City), United Ways of Gratiot and Isabella Counties (Alma and Mt. Pleasant) and the American Cancer Society – North Central Region (Southfield).
This work is being conducted as part of a consortium of comprehensive cancer centers including the University of Iowa Holden Comprehensive Cancer Center, the James Comprehensive Cancer Center at the Ohio State University, University of Colorado Cancer Center and the O’Neal Comprehensive Cancer Center at the University of Alabama – Birmingham.
About Karmanos Cancer Institute’s Office of Cancer Health Equity and Community Engagement
Karmanos Cancer Institute’s Office of Cancer Health Equity and Community Engagement’s (OCHECE) mission is to eliminate cancer health disparities in Michigan by promoting community-engaged research and evidence-based strategies throughout Karmanos’ 46-county catchment area in Michigan. OCHECE coordinates a number of efforts, including Michigan Cancer HealthLink (formerly Detroit HealthLink for Equity in Cancer Care), an academic-community partnership created to build community capacity to collaborate in cancer-related research.
About the Barbara Ann Karmanos Cancer Institute
Karmanos Cancer Institute is headquartered in Detroit, with 16 locations throughout Michigan. As part of McLaren, Karmanos is the largest cancer care and research network in the state. It is among the nation’s best cancer centers as one of the National Cancer Institute-designated comprehensive cancer centers in the United States and the only one located in metro Detroit. Karmanos cancer experts focus solely on cancer to prevent, detect and treat as well as eradicate all forms of cancer. Its long-term partnership with the Wayne State University School of Medicine enhances the collaboration of critical research and academics related to cancer care. For more information, call 1-800-KARMANOS (800-527-6266) or visit www.karmanos.org. Follow Karmanos on Facebook, Twitter and YouTube.
SOURCE Karmanos Cancer Institute
